Stock TRILC TURK ILAC VE SERUM SANAYI ANONIM SIRKETI
Add to a list
To use this feature you must be a member
Log inSign up

All News Turk Ilac Ve Serum Sanayi Anonim Sirketi

Equities

TRILC

TRETRLC00022

Delayed Borsa Istanbul
Other stock markets
 06:16:10 02/07/2024 pm IST 		5-day change 1st Jan Change
26.1 TRY +1.32% Intraday chart for Turk Ilac Ve Serum Sanayi Anonim Sirketi -0.91% +128.87%
11/06 Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04/04 Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) dropped from S&P Global BMI Index
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) added to S&P Global BMI Index
CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRILC Stock
  4. News Turk Ilac Ve Serum Sanayi Anonim Sirketi